NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

Kestra Medical Technologies, Ltd. (KMTS) Stock Analysis

Kestra Medical Technologies, Ltd. (KMTS) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

KMTS

$25.54

+$0.40 (+1.59%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare KMTS with… →

KMTS Key Statistics

As of Sep 4, 2026
Trading
Open
$25.01
Previous Close
$25.14
Day's Range
24.76–25.67
52-Week Range
16.68–30.00
Volume
181.80K
Valuation
Market Cap
$1.50B
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
15.73
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.47
Financials (FY)
Revenue (FY)
$95.13M+59.03%
Net Income (FY)
−$131.61M
Profit marginThe share of revenue left as profit after all costs and taxes.
−138.35%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
58.60M
1-Year Return
+54.69%
Dividend and dates
Earnings Date
September 14, 2026
Avg Volume
361.00K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

KMTS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−3.70%
2025 (partial year)+21.43%

As of September 4, 2026.

KMTS Revenue and Earnings by Fiscal Year

FY ends April
Fiscal yearRevenueNet incomeNet margin
2025$95.13M−$131.61M−138.4%
2024$59.82M−$113.81M−190.3%
2023$27.81M−$94.12M−338.4%
2022$7.63M−$84.24M−1104.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$95.13M$48.86M−$134.74M−$131.61M−138.4%
2024$59.82M$24.21M−$106.38M−$113.81M−190.3%
2023$27.81M$362.00K−$85.06M−$94.12M−338.4%
2022$7.63M−$10.65M−$80.42M−$84.24M−1104.0%

Annual figures as reported, in the company's reporting currency. As of April 30, 2026.

KMTS Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricKMTSMedical Instruments & Supplies medianvs median
P/S ratio15.733.175.0x the median
Profit margin−138.35%0.85%139.2 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Kestra Medical Technologies, Ltd. (KMTS) carries a market capitalisation of $1.50B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. The company reports 443 employees.

The 52-week range on file runs from $16.68 to $30.00. The most recent close on file for KMTS is $25.54, dated September 4, 2026. That is +$0.40 (+1.59%) against the previous close. The latest close sits 53.12% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $95.13M. Against the prior fiscal year total of $59.82M, that is a change of +59.03%. The same year closed with a net loss of $131.61M. Profit margin runs at −138.35%. That is 139.2 percentage points below the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to −2.47.

Across the 4 fiscal years on file, revenue moves from $7.63M in 2022 to $95.13M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 15.73 times revenue. On price-to-sales that is 5 times the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Daily returns over the trailing 1 year annualize to a volatility of 64.46%. The trailing one-year price return is +54.69%.

Growth & Income

The record shows no dividend for KMTS.

2026 is still running; the price is −3.70% year to date.

Peer Comparison

Kestra Medical Technologies, Ltd. (KMTS) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Kestra Medical Technologies, Ltd. KMTS $1.50B —
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Kestra Medical Technologies, Ltd. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington.

Visit website →